While the Castro regime boasts about national biotechnology in Asia, the immediate results in Cuba remain imperceptible.

The appointment of a former lobbyist to such an important job “bodes very poorly for what we are about to see from the next Trump administration,” said Craig Holman, himself a registered lobbyist for ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug development for Parkinson’s disease. GSK will pay $80 million ...

A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat amyotrophic lateral sclerosis with a new strategy. Trace Neuroscience ...

US pres­i­den­tial elec­tion win­ner Don­ald Trump has promised to let his al­ly Robert F. Kennedy Jr. “go wild” on drug and food pol­i­cy. While Kennedy … ...

Re­sponse Phar­ma­ceu­ti­cals be­lieves its ex­per­i­men­tal drug can lessen the per­sis­tent weight gain as­so­ci­at­ed with an­tipsy­chotics.

Adeno-associated viruses (AAVs) are promising delivery tools for gene therapy and are used in many clinical studies. However, less than ten AAV-based therapies have been approved to date. To mitigate ...

Also making the big bucks is preclinical-stage Modifi Biosciences. The American biotech was bought for a deal worth up to $1.3 billion by Merck. With this buyout, Merck aims to employ Modifi’s ...